SPRYCEL (Dasatinib)

SPRYCEL is a prescription medication that contains the active ingredient Dasatinib. It is primarily used in the treatment of certain types of leukemia, specifically chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). SPRYCEL works by inhibiting specific proteins that promote cancer cell growth, effectively slowing down or stopping the progression of the disease.